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IN order to elucidate further the possible role of specific
cytokines in the pathogenesis of atopic dermatitis (AD)
the in vitro production of interleukin 4 (IL-4) and inter-
feron-gamma (IFN-/) in patients with severe atopic der-
matitis (n 4) was compared with that in a group of
non-atopic healthy controls. Overall IL-4 production by
PHA- and PWM-driven PBMNCs was increased in con-
trols during the first 48 h in culture. Addition of inter-
leukin 2 (IL-2) into parallel cultures generated an in-
significant (p > 0.05) increase in IL-4 production in AD
patients compared with that from controls. IFN-y produc-
tion by PWM-stimulated PBMNCs was markedly de-
creased in AD patients compared with controls (p < 0.01).
Addition of IL-2 (250 U/ml) to parallel cultures failed to
restore IFN-y production in AD patients. Finally, no IL-4
or IFN-y activity could be detected in any of the sera. In
conclusion, the data suggest a possible dysregulation of
cytokine production in at least a subgroup ofAD patients,
with an impaired capacity to secrete IFN-y, but a partially
intact IL-4 generating capacity.
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Introduction
Although atopic dermatitis (AD) is a chronic,
pruritic, inflammatory skin disorder first described
as a disease entity in the early decades of this
century, its etiopathogenesis has not yet been fully
elucidated. In addition to genetic disposition, AD
is influenced by many environmental factors.
Numerous humoral and cellular immunological
abnormalities have been reported in AD, including
high IgE levels, increased numbers of IgE-Fc
receptor (FceR) bearing lymphocytes, and cellular
dysfunctions in T-cells. In the murine system2’3 as
well as in humans4 T-helper cells can be divided
into two subsets (TH1 and TH2) on the basis of the
cytokines they produce: TH cells secrete inter-
leukin 2 (IL-2) and interferon-gamma (IFN-2) and
TH2 cells secrete interleukin 4 (IL-4) and interleukin
5 (IL-5). Evidence has accumulated that the human
IgE response is mainly regulated by the relative
production of the reciprocally active cytokines IL-4
(TH2 system) and IFN-2 (TH system),
s-8 Both
recombinant and natural IL-4 induce IgE synthesis
by peripheral blood mononuclear cells (PBMNCs)
from atopic and healthy donors.9- IFN-y down-
regulates this IL-4 induction of IgE synthesis in
vitro,s’2-14 It has been suggested that in atopic
individuals allergens may ’select’ T-helper cells
with peculiar profiles of cytokine production (high
IL-4 and low IFN-,), thus contributing to the
pathogenesis of IgE-mediated disorders.
6 Only a
few studies have investigated the simultaneous
production of IL-4 and IFN-y in vitro using
activated PBMNCs cultures from atopic do-
nors.s-7 The results have been in part controversial
with respect to IL-4s-7’18 and IFN-/16’7’9’2
production. These data prompted the authors to
examine whether IL-4 and IFN-2 activity could be
detected in the supernatants (SN) of plant
lectin-stimulated (PHA and PWM) PBMNC cul-
tures from AD patients with moderate to severe
disease activity using commercially available
ELISAs.2 In order to investigate the in vitro effect
of IL-2, a T-cell growth factor described as being
22 23 required for IL-4 production as well as capable
of mediating IFN-, generation,
24 exogeneous
rhIL-2 was added to parallel PBMNC cultures. We
finally investigated whether PBMNCs from atopic
patients with severe disease scores produced altered
levels of IL-4 and IFN-y compared with those from
controls.
Materials and Methods
Subjects: Four atopic patients (all male; mean age
12 years, range 9-14 years) were selected on the
basis of a positive history for allergies. They all
suffered from atopic dermatitis as defined by the
criteria of Hanifin and Rajka,
2s allergic rhinitis
and mild or severe allergic asthma, and had
elevated serum total IgE levels (mean 4714 IU/ml,
range 222-10920 IU/ml) using the Phadezym
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IgE Prist test (Pharmacia Biosystems, Freiburg,
Germany). Three of four atopic patients had acute
exacerbation of AD, with severe episodes of
itching, paralleled by nocturnal asthmatic attacks,
requiring various therapeutic regimens including
topical emollients, ambulant photo-balneotherapy
and/or elimination diets. The control group
consisted of four healthy individuals (all male;
mean age 20 years, range 8-29 years) with a
negative history of atopy; their total serum IgE
levels were <50 IU/ml; no elevated specific IgE
levels to the most common allergens were
detected in the sera using the Phadezym RAST
test (Pharmacia).
Reagents: RPMI 1640 medium, supplemented with
300mg/ml L-glutamine, 100U/ml penicillin, 100
mg/ml streptomycin, 10% heat-inactivated (30 min,
56C) foetal bovine serum, and 25 mM HEPES
buffer, phytohaemagglutinin (PHA), pokeweed
mitogen (PWM), and recombinant human inter-
leukin 2 (rhIL-2) were all obtained from Sigma
Chemie, Deisenhofen, Germany. Ficoll-Hypaque
(R)
was obtained from Pharmacia, Freiburg, Germany.
Cells and cultures: PBMNCs were isolated from
heparinized peripheral blood by centrifugation on
a density gradient of Ficoll-Hypaque,
26 extensively
washed and resuspended at 106 cells/ml of complete
medium. 200/,1 of cell suspension/well were
cultured with or without PHA or PWM (at final
concentrations of 5.0/,g/ml), either in the presence
or absence of IL-2 (250 U/ml) in 96-well,
flat-bottomed, polystyrene microtitre plates (Corn-
ing(R), Sigma Chemie) at 37C, 95% humidity, and
10% CO2 in air for 48 h. At 24 h and 48 h after
initiation the culture supernatants (SN) were
harvested by centrifuging the samples at 350 x g,
for 10 min at room temperature. The cell pellets
were resuspended in fresh complete RPMI 1640
medium. The SNs were stored in aliquots at -70C
until tested.
Cytokine assays: IL-4 was determined in the SNs of
the PBMNC cultures using a commercially available
ELISA (Quantikine(R), Biermann Diagnostics, Bad
Nauheim, Germany). The same technique was used
for measuring IL-4 in the donors’ sera, which were
frozen at --20C 1 h after collection and centrifuga-
tion. The calculated lower limit of detection of this
ELISA is 2-3 pg/ml with a confidence of 96%. The
SNs and sera were assayed for IFN- with a
commercially available ELISA for human IFN-3;
(HBT, Biermann Diagnostics). According to the
manufacturer 1 unit of natural human IFN-),
corresponds to between 50 and 100 pg, depending
on the batch. Each sample was measured in
duplicate unless stated otherwise.
[3H]-thymidine incorporation assay" Proliferation of the
PBMNCs in culture was assessed by a standard
[3H]-thymidine incorporation assay.
Statistical evaluations: Differences in levels of IL-4 and
IFN-;; between AD patients and controls were
analysed by Student’s t-test. Correlations between
cytokine production and IgE serum concentration
were calculated by simple linear regression analysis
and tested for statistical significance. Owing to the
small samples sizes, descriptive rather than
confirmatory statistics were intended.
Results
IL-4 and IFN- in human serum" No IL-4 or IFN-
activity could be detected in the non-concentrated
sera from AD patients or healthy controls with
the above described ELISA techniques (IL-
4 < 3 pg/ml resp. IFN-2 < 1 pg/ml).
Time course of cytokine production in PBMNC cultures: IL-4
and IFN-2 were not spontaneously secreted by
PBMNCs from either group. The time courses
(over 48 h) of cytokine production by PBMNCs
fromAD patients after addition ofPHA (5.0/,g/ml)
or PWM (5.0/g/ml) are shown in Fig. 1.
IL-4 and1FN-2 production inPBMNC cultures (at 24 h)
Effects of PWM stimulation" PWM (5.0 #g/ml)-
induced IL-4 production (at 24 h) by PBMNCs
from AD patients was not increased significantly
compared with controls. PWM-induced IFN-3;
generation (at 24h) in AD patients (mean
5.5-t-5.4 U/ml) was decreased significantly @ <
0.01) compared with controls (mean 42.5_
12.3 U/ml)(Fig. 2).
Effects of PHA stimulation. PHA (5.0 #g/ml)-
induced IL-4 production as well as IFN-2
generation (at 24 h) by PBMNCs from AD patients
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FIG. 1. Kinetics of in vitro IL-4 and IFN- production by PBMNCs from
AD patients (n 4) with increased serum IgE levels; 106 PBMNCs/ml of
complete RPMI 1640 medium were stimulated with 5 #g/ml of PHA or
5/g/ml of PWM. After 24 and 48 h, SNs were harvested and assayed for
IL-4 (PHA plain triangles; PWM open squares) and IFN- (PHA
plain squares; PWM stars) activity. Each sample was measured in
duplicate. Values are expressed as means-t-S.E.M.
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FIG. 2. Cytokine production in vitro by PWM-stimulated PBMNCs.
PWM-induced IL-4 generation by PBMNCs from AD patients (hatched
bars) (at 24 h) was not significantly increased (p _< 0.05) compared with
that from controls (open bars). PWM-induced IFN-y generation (at 24 h)
in AD patients (mean 5.5 -I- 5.4 U/ml) was significantly decreased
(p < 0.01) compared with that in controls (mean 42.5 _+ 12.3 U/ml).
Values are expressed as means +_ S.E.M.
did not dier significantly from controls (data not
shown).
EJfects of IL-2 supplementation. In order to
investigate the IL-2 requirement for IL-4 gen-
eration, rhlL-2 (250 U/ml) was added with PWM
or PHA. IL-2 supplementation did not increase
IL-4 production significantly in AD patients and
controls. We furtherinvestigated whether IL-2 can
restore the impaired IFN-2 production in AD
patients. No significant difference was observed
between IFN-2 secretion (at 24 h) upon PWM plus
IL-2 stimulation compared with PWM stimulation
alone (Fig. 3) or PHA plus IL-2 stimulation
compared with PHA stimulation alone.
Correlation between cytokine production and IgE serum
concentration: A significant positive correlation existed
between in vitro PHA- (r 0.85, p < 0.05) and
PWM- (r 0.98, p < 0.00005) induced IFN-2
10
FIG. 3. Effects of IL-2 addition on PWM-induced cytokine production.
Addition of IL-2 (250 U/ml) to PWM-stimulated PBMNCs (black bars)
of AD patients did not significantly increase IL-4 production (at 24 h)
compared with that of cultures grown with PWM alone (open bars). No
significant difference was observed between FN-y secretion (at 24 h)
upon PWM plus IL-2 stimulation compared with PWM stimulation alone.
Values are expressed as means ___
S.E.M.
secretion and total IgE serum concentration in AD
patients; no significant correlation was observed
between PHA or PWM-induced IL-4 secretion and
total IgE serum concentration (data not shown).
Discussion
In this study the in vitro production of IL-4 and
IFN-2 by PBMNCs from AD patients was
compared with that of healthy controls. In
agreement with other published data, neither IL-416
nor IFN-219 could be detected in any of the sera.
This is in contrast to data published by Matsumoto
et al.,
27 where serum concentrations of IL-4 could
be measured in children with allergic diseases as
well as in non-allergic controls. Differences in the
IL-4 assays used might partly account for these
discrepancies.
More importantly, in vitro PWM-induced IFN-y
production by PBMNCs from AD patients was
significantly lower compared with controls (Fig. 2).
An accepted view is that the elevated serum IgE
levels in atopic individuals are a consequence of
imbalances between IL-4-producing and IFN-2-
producing helper T-cells.
28 Parronchi et al.
29
suggested that the high amounts of IL-4 without
simultaneous IFN-y production by allergen-specific
TH cells induces the formation of IgE antibodies.
The defective IFN-2 production in AD patients
observed here might not be able to successfully
down-regulate IL-4-induced IgE synthesis in vivo in
these individuals, whereas high IFN-2 levels in
healthy controls might successfully antagonize the
IL-4-induced IgE synthesis. However, as un-
separated PBMNCs were used as the cell source in
this study the potential contribution of monocytes
to the measured IFN-y production is diflqcult to
assess. Del Prete et al.
3 reported defective IFN-2
production in the hyper IgE syndrome. A severe
deficiency in IFN-2 production by PBMNCs from
AD patients was observed after PHA stimula-
tion3’2 as well as concanavalin stimulation. In this
study defective IFN-2 production in AD patients
has been shown by using PWM, another lectin that
does not bypass the transmembrane signalling when
stimulating PBMNCs.
As IL-2 can mediate mitogen-induced IFN-2
production,
24 the authors investigated whether
stimulation with mitogen plus IL-2 could restore
decreased IFN-2 production by PBMNCs in vitro.
Supplementing PBMNCs from AD patients with
up to 250 U/ml of IL-2 failed to restore PWM- or
PHA-induced IFN-2 production. At this final
concentration even IL-2 had a depressive effect on
IFN-2 production. Taken together, these data
suggest that the reported defective IL-2 produc-
tion4 in AD patients is possibly not responsible for
the decreased IFN-2 production by PBMNCs.
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The observed positive correlation in AD patients
between in vitro IFN-y production and total serum
IgE is in apparent conflict with the view that IFN-y
down-regulates IgE production and in contrast
with another report.
31
The data presented here do not demonstrate a
significant difference between PHA/PWM-induced
IL-4 production in AD patients and controls (Fig.
2). Supplementation with IL-2 (250 U/ml) failed to
induce a significant increase in IL-4 generation from
PHA/PWM-stimulated PBMNCs from AD
patients. Seder et al.
35 have shown that the
frequency of IL-4 producing cells is very low
among circulating antigen-primed T-cells; further-
more several groups recently reported evidence for
the accumulation and expansion of T-lymphocytes
producing high amounts of IL-4 in lesional skin,
whereas T-lymphocytes from peripheral blood were
poor IL-4 producers. 36’37 Further investigations
should compare the cytokine profiles from lesional
skin cells and the data obtained here from peripheral
blood cells in the same AD individuals. However
it is remarkable that, despite the now accepted view
that IFN-), and IL-4 predominantly act at a local
level, a highly significant decreased in vitro IFN-2
production can be observed among peripheral
blood MNCs.
In contrast to IL-4, no correlation between IFN-2
production and cell proliferation was observed.
However, Patarca et al.38 demonstrated that
activation of TH1 cells does not necessarily result in
IFN-y production.
In conclusion, although the number of invest-
igated individuals is small, we could demonstrate a
defective in vitro IFN-y production in PBMNCs
from patients with mild to severe forms ofAD and
moderate to high total serum IgE concentrations,
whereas no significant difference in IL-4 secretion
was observed in these patients when compared with
controls.
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